Immediate 8% Sevoflurane Induction in Children: a Comparison with Incremental Sevoflurane and Incremental Halothane
Overview
Affiliations
We compared the efficacy and tolerance of pediatric inductions with immediate 8% sevoflurane in 70% nitrous oxide with either incremental sevoflurane or incremental halothane in 70% nitrous oxide. Forty-six unpremedicated children had anesthesia induced by immediate 8% sevoflurane (high sevoflurane [HS]; circuit primed with 70% N2O and 8% sevoflurane before application of the face mask), gradual sevoflurane (GS; primed with 70% N2O with increments of sevoflurane), and gradual halothane (HAL; 70% N2O with incremental halothane). Blind video recordings were made, and each child's distress was rated prior to mask application, during mask application, and every 10 s thereafter using a behavioral rating scale. There were no complications. Of those subjects not quiet and cooperative throughout, times to complete quiet were significantly different (P = 0.001): HS 19.8 +/- 8 s (range 9-34); GS 52 +/- 17 s (range 8-73); HAL 43 +/- 22 s (range 13-73). Times to eye closure were also significantly different (P < 0.001): HS 37 +/- 10 s (range 15-56); GS 70 +/- 18 s (range 35-114); HAL 81 +/- 34 s (range 55-140). Distress scale scores showed more rapid decrement with HS than with GS or HAL. We conclude that 1) immediate 8% sevoflurane/N2O results in a significantly faster induction than GS or HAL;2) in children, HS in N2O will not result in a single-breath induction under the conditions of this study; 3) in this small group, HS was extremely well tolerated in ASA class I and II patients.
Feng J, Wang X, Lu Y, Pang D, Peng W, Mo J J Int Med Res. 2017; 45(3):912-923.
PMID: 28425829 PMC: 5536403. DOI: 10.1177/0300060517704595.
Comparison of speed of inhalational induction in children with and without congenital heart disease.
Hasija S, Chauhan S, Jain P, Choudhury A, Aggarwal N, Pandey R Ann Card Anaesth. 2016; 19(3):468-74.
PMID: 27397451 PMC: 4971975. DOI: 10.4103/0971-9784.185531.
Boonmak P, Boonmak S, Pattanittum P Cochrane Database Syst Rev. 2016; (6):CD006837.
PMID: 27356171 PMC: 8676071. DOI: 10.1002/14651858.CD006837.pub3.
De Hert S, Moerman A F1000Res. 2015; 4(F1000 Faculty Rev):626.
PMID: 26380072 PMC: 4560253. DOI: 10.12688/f1000research.6288.1.
Schultz B, Otto C, Schultz A, Osthaus W, Krauss T, Dieck T PLoS One. 2012; 7(7):e40903.
PMID: 22829896 PMC: 3400655. DOI: 10.1371/journal.pone.0040903.